Wuhan Zonke Optoelectronic Technology Co., Ltd.
Premium Semiconductor Ultraviolet Light Therapy Device
Niu Baik Therapy Device
The nemesis of psoriasis, psoriatic arthritis, and vitiligo.
The Niubaike 308/365 nm laser therapy device is a cutting-edge laser‑based instrument developed by the Chinese Academy of Sciences. It features a patented aluminum gallium nitride crystal light‑emitting technology, offering a pure light source, low power consumption, comprehensive treatment coverage with no blind spots, and exceptional safety and reliability. This design enhances the precision and targeted delivery of therapy, while its light‑radiation intensity is several times that of conventional ultraviolet light, enabling rapid penetration to the lesion and improving patient tolerance. It is a high‑tech medical device for the treatment of vitiligo, scleroderma, psoriasis, and erythematous skin disorders.
Product Features
01
Semiconductor crystal invention patent technology, with pure light source and strong irradiation.
02
Continuous irradiation enhances the skin’s tolerance and its absorption rate of light energy.
03
Anti-white treatment works quickly, with immediate results.
04
When combined with 365-nm wavelength light and used in conjunction with other therapies, it can rapidly stimulate the proliferation of dermal and follicular pigments.
Technical Principle
By directly applying the 308 nm laser beam to the localized dermal layer of the vitiligo lesions.
It induces apoptosis of T lymphocytes to achieve therapeutic effects, addressing the root cause of melanocyte destruction while simultaneously stimulating the proliferation of residual melanocytes and promoting the synthesis of vitamin D3, thereby creating a favorable microenvironment for melanocyte regeneration. For patients with various types of vitiligo who are unsuitable for melanocyte transplantation or pharmacological treatment—particularly pregnant women and children—the 308 nm laser therapy device is the treatment of choice.
Upgradable dual-system, Bullwhite K308/365nm, 365nm
The therapeutic principle of 365-nm laser treatment: UVA1 phototherapy (wavelength 340–400 nm), a long‑wave ultraviolet light, is a relatively new phototherapeutic modality that was first introduced into dermatological clinical practice in 1992. UVA1’s unique spectral characteristics confer strong tissue penetration, promoting the expression of matrix metalloproteinases in dermal fibroblasts, inhibiting collagen synthesis, and reducing inflammatory cell infiltration, thereby achieving therapeutic effects in conditions such as scleroderma, keloids, neurodermatitis, and seborrheic dermatitis.
Scope of Application
[Vitiligo, Psoriasis, Scleroderma]
[Polymorphic Light Eruption, Chronic Actinic Dermatitis, Solar Urticaria]
【Atopic Dermatitis and Eczema】
[Pre-tibial Myxedema]
[Lichen Planus, Systemic Lupus Erythematosus]
[Callus-like swelling, hand dyshidrotic eczema]
[Allergic dermatitis and other cutaneous immune diseases]
Clinical application
Before treatment
Next treatment
Two treatments
Honors and Qualifications
Classic customer
Related products